Connection
Robert Fuhlbrigge to Immunologic Factors
This is a "connection" page, showing publications Robert Fuhlbrigge has written about Immunologic Factors.
|
|
Connection Strength |
|
 |
|
 |
|
0.061 |
|
|
|
-
El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. J Pediatr. 2007 Apr; 150(4):376-82.
Score: 0.061